» Articles » PMID: 36455046

Medication Related Problems Among Ambulatory Patients with Chronic Kidney Disease at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia

Overview
Journal PLoS One
Date 2022 Dec 1
PMID 36455046
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Medication related problem (MRP) is an event occurring, as a result, the medication therapy that actually or potentially interferes with desired health outcomes. Evidences reported that the prevalence of MRPs may result in a high burden of morbidity and decrease patients' quality of life. The problem is more significant among patients with chronic kidney disease (CKD) as a decline in kidney function and increase number of medications required to treat kidney disease and its complications. Thus, this study aimed to assess MRPs and its associated factors among patients with chronic kidney disease.

Method: Hospital-based cross-sectional study was conducted among 248 adult ambulatory patients with CKD (stage 1-4) at St. Paul's Hospital Millennium Medical College. Data were collected through patient interview and medical chart review from 1st of June to 30th of August 2019. MRPs were identified based on the standard treatment guidelines. Cipolle MRPs classification was used to classify the MRPs and Micromedex® was used as drug interaction checker. Binary logistic regression was utilized to identify the associated factors and p value <0.05 was considered as statistically significant.

Result: A total of 325 MRPs were identified from 204 (82.3%) study participants giving 1.6 MRPs per participant. One MRP was identified among 114 (55.9%) patients while two MRPs were identified among 64 (31.4%). The most common class of MRPs were need additional drugs 114 (35.1%) followed by non-compliance 54 (16.6%), unnecessary drug therapy 46 (14.2%) and dose too low 46 (14.2%). The two most common reasons for non-compliance were unaffordability of drugs 26(48.1%) and the lack of patient understanding about drug taking instruction 10 (18.5%). The study showed that only occupation (AOR = 5.2, 95% CI: 1.292-21.288, P = 0.020) and angiotensin converting enzyme inhibitor use (AOR = 6.6, 95% CI: 2.202-19.634, P = 0.001) had an association with the occurrence of MRPs.

Conclusion: The prevalence of MRPs among ambulatory patients with CKD was high and need of additional drug therapy was the commonest MRPs.

Citing Articles

The Prevalence and Impact of Clinical Pharmacists' Intervention on Drug-Related Problems in Patients With Chronic Kidney Disease.

Alam K, Hayat A, Ullah A, Syed Sulaiman S, Ahmad W, Ooi G Cureus. 2024; 16(4):e59402.

PMID: 38817515 PMC: 11137644. DOI: 10.7759/cureus.59402.


Factors Contributing to Negative Outcomes Associated with Medications and Drug-Related Problems in Kidney Replacement Therapy-A Hospital-Based Prospective Observational Study.

Pereira-Cespedes A, Jimenez-Morales A, Polo-Moyano A, Palomares-Bayo M, Martinez-Martinez F, Angel Calleja-Hernandez M J Clin Med. 2024; 13(4).

PMID: 38398360 PMC: 10888631. DOI: 10.3390/jcm13041048.


Drug-related problems and associated factors among patients with kidney dysfunction at a tertiary hospital in southwestern Uganda: a prospective observational study.

Kyomya J, Atwiine F, Shegena E, Muhindo R, Yadesa T BMC Nephrol. 2023; 24(1):375.

PMID: 38114948 PMC: 10731752. DOI: 10.1186/s12882-023-03437-2.


Frequency, types and predictors of drug therapy problems among non-dialysis chronic kidney disease patients at a tertiary care hospital in Pakistan.

Hayat M, Ahmad N, Mohkumuddin S, Khan S, Khan A, Haq N PLoS One. 2023; 18(4):e0284439.

PMID: 37058504 PMC: 10104314. DOI: 10.1371/journal.pone.0284439.

References
1.
Woo K, Choong H, Wong K, Tan H, Chan C . The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2012; 81(10):1044-1045. DOI: 10.1038/ki.2012.39. View

2.
Alahdal A, Elberry A . Evaluation of applying drug dose adjustment by physicians in patients with renal impairment. Saudi Pharm J. 2013; 20(3):217-20. PMC: 3745053. DOI: 10.1016/j.jsps.2011.12.005. View

3.
Quintana-Barcena P, Lord A, Lizotte A, Berbiche D, Lalonde L . Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies. J Manag Care Spec Pharm. 2018; 24(2):173-181. PMC: 10398068. DOI: 10.18553/jmcp.2018.24.2.173. View

4.
Belaiche S, Romanet T, Allenet B, Calop J, Zaoui P . Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. J Nephrol. 2012; 25(5):782-8. DOI: 10.5301/jn.5000063. View

5.
Kefale B, Tadesse Y, Alebachew M, Engidawork E . Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study. PLoS One. 2018; 13(7):e0200415. PMC: 6059431. DOI: 10.1371/journal.pone.0200415. View